StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.29−0.44 (-6.54%)

Close on Nov 16, 2026Market cap $283.18MP/E –Yield –

How the market prices Agenus

Each ratio against its own distribution since 2015, from month-end prices and the figures reported at the time

Agenus trades at 2.1× its earnings, against a median of 1.4× since 2015 — close to the middle of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2015, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2015

Median 1.4×, today 2.1×

Margins

Gross margin99.5%vs 52.8%
Operating margin27.3%vs -42.9%
EBITDA margin30.8%vs -29.3%
Free cash flow margin-74.2%vs -9.41%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

How hard the assets work

Revenue per dollar of assets0.74vs 0.39
Revenue per employee$1.64Mvs $405.05K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $11.33M, or 0.3 times a year of EBITDA. That is 1.6% of the $287.73M it would cost to buy the business outright.

Total debt$30.07M
Cash and short-term investments$18.74M
EBITDA, trailing twelve months$40.93M
Free cash flow, trailing twelve months-$98.50M

Leverage and liquidity

Debt to EBITDA0.73vs 3.42
Net debt to EBITDA0.28vs 2.33
Current ratio0.34vs 3.28
Quick ratio0.14vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

-16.54
DistressGrey zoneSafe

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Free cash flow yield-34.8%vs -9.68%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 16, 2026

$2.7152-week low52-week high$10.31
200-day$6.2920-day50-day

The close sits 47% of the way up the 52-week range, 39.0% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

42
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

AGENS&P 500
PeriodAGENS&P 500DifferenceAGEN per yearS&P 500 per year
1 month+4.1%-3.1%+7.2 pts
3 months-14.1%-4.5%−9.6 pts
Year to date+100.3%+9.4%+91.0 pts
1 year+44.9%+11.3%+33.6 pts
3 years-55.1%+70.4%−125.5 pts-23.4%+19.4%
5 years-91.3%+68.6%−159.9 pts-38.7%+11.0%
10 years-94.3%+297.7%−392.0 pts-24.9%+14.8%

How much it moves

Volatility, 1 year120.6%vs 80.5%
Volume against its 90-day average0.18vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

8M AGEN shares were sold short on Oct 30, 2026, up 8.5% from the previous report, or 18.06% of the shares available to trade. At recent volumes it would take 10.7 days to buy them back. Over the last 20 sessions, 52.4% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float18.1%vs 8.89%
Short interest as a share of all shares16.9%vs 6.30%
Days of volume to buy it back10.68vs 5.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20267,596,037+8.5%711,09210.7
Oct 15, 20267,002,898+2.7%1,079,1136.5
Sep 30, 20266,818,562+0.2%1,205,6745.7
Sep 15, 20266,803,686+1.7%885,7097.7
Aug 31, 20266,689,181+14.1%1,096,9996.1
Aug 14, 20265,863,005-5.9%1,495,7593.9
Jul 31, 20266,232,820-11.7%2,045,1593.0
Jul 15, 20267,057,525+17.7%18,443,3511.0
Jun 30, 20265,994,778+25.5%1,105,5415.4
Jun 15, 20264,777,994-12.6%574,7848.3
May 29, 20265,464,046+2.8%660,4108.3
May 15, 20265,316,189+21.2%874,6786.1

Every measure, in full

72 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 15, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 16, 2026

Valuation ratiosIndustry

Market Cap
$283.18M
$254.69M
Enterprise Value
$287.73M
$130.88M
PS Ratio
2.13
3.66

Enterprise valuationIndustry

EV / Sales
2.17
2.38
EV / EBITDA
7.03
16.00
EV / EBIT
7.95
18.86

Share statisticsIndustry

Shares Change (YoY)
51.1%
11.0%
Shares Change (QoQ)
10.6%
0.57%
Float
42M
49M
Shares Held by Insiders
6.59%
11.3%
Shares Held by Institutions
31.7%
56.3%

Short sellingIndustry

Short Interest
8M
–
Short Interest Change
8.47%
-0.80%
Short % of Float
18.1%
8.89%
Short % of Shares Outstanding
16.9%
6.30%
Days to Cover
10.68
5.13

Stock price statisticsIndustry

52-Week High
$10.31
–
52-Week Low
$2.71
–
20-Day Moving Average
$6.73
–
50-Day Moving Average
$7.33
–
200-Day Moving Average
$5.13
–
Average True Range (14)
$0.51
–
Price Change (1 Week)
-12.0%
-7.83%
Price Change (1 Month)
4.14%
-6.48%
Price Change (3 Months)
-16.5%
-26.6%
Price Change (6 Months)
99.1%
-22.2%
Price Change (YTD)
100.3%
-25.6%
Price Change (1 Year)
45.3%
-23.8%
Price Change (3 Years)
-54.4%
-32.9%
Price Change (5 Years)
-91.2%
-77.3%
Price Change (10 Years)
-93.6%
-66.7%
Average Volume (10 Days)
693,263
–
Average Volume (20 Days)
683,530
–
Average Volume (90 Days)
3M
–
Relative Volume
0.18
0.86
Relative Strength Index (14)
41.5
40.3
Volatility (1 Year)
120.6%
80.5%

MarginsIndustry

Gross Margin
99.5%
52.8%
Operating Margin
27.3%
-42.9%
EBITDA Margin
30.8%
-29.3%
FCF Margin
-74.2%
-9.41%

Financial positionIndustry

Current Ratio
0.34
3.28
Quick Ratio
0.14
2.37
Debt / EBITDA
0.73
3.42
Net Debt / EBITDA
0.28
2.33
Interest Coverage
0.61
-6.20

GrowthIndustry

Revenue Growth (YoY)
30.5%
5.68%
Revenue Growth (3Y CAGR)
5.22%
2.25%
Revenue Growth (5Y CAGR)
5.31%
6.41%

EfficiencyIndustry

Asset Turnover
0.74
0.39
Revenue Per Employee
$1.64M
$405.05K
Employee Count
81
75

Income statement (TTM)Industry

Revenue
$132.69M
$58.79M
Gross Profit
$132.05M
$103.58M
Operating Income
$36.20M
-$21.49M
EBITDA
$40.93M
-$17.14M

Balance sheetIndustry

Total Debt
$30.07M
$114.91M
Net Cash (Debt)
-$11.33M
$15.31M
Net Cash Per Share
-$0.25
$0.72
Equity (Book Value)
-$199.08M
$49.40M
Book Value Per Share
-$4.42
$1.45
Tangible Book Value
-$226.05M
$23.58M
Working Capital
-$153.01M
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
-$98.50M
-$12.17M
Capital Expenditures
$0
-$1.02M
Free Cash Flow
-$98.50M
-$20.44M
FCF Per Share
-$2.19
-$0.42

Dividends and yieldsIndustry

FCF Yield
-34.8%
-9.68%

Taxes and interestIndustry

Interest Expense
$59.35M
$3.07M

Scores and fair valueIndustry

Altman Z-Score
-16.54
0.12

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?